Basic Information
| LncRNA/CircRNA Name | XLOC014172 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR |
| Sample | plasma |
| Expression Pattern | differential expression |
| Function Description | Among the ten candidate circulating lncRNA, LINC00152, RP11-160H22.5, XLOC014172 and LOC149086 were screened with significant difference in training set. Further investigation in validation set indicated LINC00152, RP11-160H22.5 and XLOC014172 might be the fingerprints for HCC comparing with chronic hepatitis (CH) patients or healthy controls |
| Pubmed ID | 29130980 |
| Year | 2017 |
| Title | Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma |
External Links
| Links for XLOC014172 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |